pC015 - dLwCas13a-NF Citations (4)

Originally described in: RNA targeting with CRISPR-Cas13.
Abudayyeh OO, Gootenberg JS, Essletzbichler P, Han S, Joung J, Belanto JJ, Verdine V, Cox DBT, Kellner MJ, Regev A, Lander ES, Voytas DF, Ting AY, Zhang F Nature. 2017 Oct 4. doi: 10.1038/nature24049. PubMed Journal

---

Articles Citing pC015 - dLwCas13a-NF

Articles
Long noncoding RNA LISPR1 is required for S1P signaling and endothelial cell function. Josipovic I, Pfluger B, Fork C, Vasconez AE, Oo JA, Hitzel J, Seredinski S, Gamen E, Heringdorf DMZ, Chen W, Looso M, Pullamsetti SS, Brandes RP, Leisegang MS. J Mol Cell Cardiol. 2018 Mar;116:57-68. doi: 10.1016/j.yjmcc.2018.01.015. Epub 2018 Feb 3. PubMed
A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1. Zhang N, Bewick B, Xia G, Furling D, Ashizawa T. Front Genet. 2020 Dec 10;11:594576. doi: 10.3389/fgene.2020.594576. eCollection 2020. PubMed
Live imaging of RNA and RNA splicing in mammalian cells via the dcas13a-SunTag-BiFC system. Chen M, Sui T, Yang L, Qian Y, Liu Z, Liu Y, Wang G, Lai L, Li Z. Biosens Bioelectron. 2022 May 15;204:114074. doi: 10.1016/j.bios.2022.114074. Epub 2022 Feb 4. PubMed
Transcript-specific induction of stop codon readthrough using a CRISPR-dCas13 system. Manjunath LE, Singh A, Devi Kumar S, Vasu K, Kar D, Sellamuthu K, Eswarappa SM. EMBO Rep. 2024 Apr;25(4):2118-2143. doi: 10.1038/s44319-024-00115-8. Epub 2024 Mar 18. PubMed

If you have published an article using this material, please email us at to have your article added to this page.